|Bid||43.84 x 1200|
|Ask||43.93 x 1800|
|Day's Range||43.30 - 45.40|
|52 Week Range||24.87 - 129.71|
|Beta (5Y Monthly)||2.81|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 08, 2021 - Nov 12, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||78.46|
Subscribe to Yahoo Finance Plus to view Fair Value for ARCTLearn more
ARK Invest founder Cathie Wood doesn't mind going against the grain. Here are three beaten-down stocks Wood is buying that Wall Street thinks will skyrocket. Shares of Arcturus Therapeutics (NASDAQ: ARCT) are still more than 60% below the highs from December despite a partial rebound this summer.
The annual LD Micro Conference was held recently and Real Money's Jim Collins was on hand to evaluate potential micro-cap stock winners. "It's the Woodstock of micro-capitalism," Collins wrote in Real Money.
LD Micro's fearless leader, Chris Lahiji, had to shut things down last year, owing to the pandemic, but, unlike other conferences scheduled for the fourth quarter, decided to go to hybrid mode this year instead of fully remote. CEOs, CFOs, buy-siders, individual investors ... everyone shows up to LD Micro.